<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04505540</url>
  </required_header>
  <id_info>
    <org_study_id>CHRMS: 18-0695</org_study_id>
    <secondary_id>1R21DA049859-01</secondary_id>
    <nct_id>NCT04505540</nct_id>
  </id_info>
  <brief_title>Start Treatment and Recovery for Opioid Use Disorder</brief_title>
  <acronym>STAR</acronym>
  <official_title>Effectiveness of Bridge Clinic Following Emergency Department-Initiated Intervention for Opioid Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Substance Abuse and Mental Health Services Administration (SAMHSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is 1) to evaluate whether emergency department-initiated medically&#xD;
      assisted treatment with Buprenorphine/Naloxone in patients presenting with opioid use&#xD;
      disorder will produce positive outcomes at 1 week, 3 months and 6 months after treatment&#xD;
      initiation, and 2) to determine whether emergency department referrals to a bridge clinic&#xD;
      improve outcomes relative to direct referrals to a local waivered physician.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The emergency department is a critical missed opportunity to engage patients with opioid use&#xD;
      disorder in medication-assisted treatment, the most effective current treatment for the&#xD;
      disorder. Patients presenting at the emergency department with opioid use disorder will be&#xD;
      given the opportunity to immediately start medication assisted treatment with&#xD;
      Naloxone/Buprenorphine then referred either to a specialized addiction bridge clinic or a&#xD;
      local waivered provider for further treatment. Differences in outcomes related to whether the&#xD;
      patient is referred to a bridge clinic or local provider will be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-report treatment retention</measure>
    <time_frame>1 week</time_frame>
    <description>Enrollment in treatment for opioid use disorder after 1 week</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-report treatment retention</measure>
    <time_frame>3 momths</time_frame>
    <description>Enrollment in treatment for opioid use disorder after 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self report treatment retention</measure>
    <time_frame>6 months</time_frame>
    <description>Enrollment in treatment for opioid use disorder after 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinalysis for illicit opioid use</measure>
    <time_frame>1 week</time_frame>
    <description>Urine analyzed for opioids (buprenorphine, methadone, oxycodone, hydrocodone, hydromorphone, heroin, fentanyl) and other drugs (cocaine, amphetamines, benzodiazepines, cannabinoids) via enzyme multiplied immunoassay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinalysis for illicit opioid use</measure>
    <time_frame>3 months</time_frame>
    <description>Urine analyzed for opioids (buprenorphine, methadone, oxycodone, hydrocodone, hydromorphone, heroin, fentanyl) and other drugs (cocaine, amphetamines, benzodiazepines, cannabinoids) via enzyme multiplied immunoassay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinalysis for illicit opioid use</measure>
    <time_frame>6 months</time_frame>
    <description>Urine analyzed for opioids (buprenorphine, methadone, oxycodone, hydrocodone, hydromorphone, heroin, fentanyl) and other drugs (cocaine, amphetamines, benzodiazepines, cannabinoids) via enzyme multiplied immunoassay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Opioid-use Disorder</condition>
  <condition>Mental Disorder</condition>
  <condition>Opioid Medication Assisted Treatment</condition>
  <arm_group>
    <arm_group_label>Bridge Clinic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medication assisted treatment supervised by addiction bridge clinic until stabilized in treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local Waivered Physcian</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medication assisted treatment supervised by local waivered physician.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bridge Clinic</intervention_name>
    <description>Specialized addiction bridge clinic</description>
    <arm_group_label>Bridge Clinic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Local Waivered Physician</intervention_name>
    <description>Direct referral to local waivered physician</description>
    <arm_group_label>Local Waivered Physcian</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient at Emergency Department&#xD;
&#xD;
          -  Diagnosis opioid use disorder according to criteria Diagnostic and Statistical Manual&#xD;
             (DSM) 5&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participating in alternate treatment program for opioid use disorder&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Inability to communicate&#xD;
&#xD;
          -  Psychosis&#xD;
&#xD;
          -  Suicidality&#xD;
&#xD;
          -  History of Buprenorphine injection&#xD;
&#xD;
          -  Critical Illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael S Mackey, PhD</last_name>
    <phone>(802) 847-8767</phone>
    <email>msmackey@uvm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roz Bidad, RN</last_name>
    <phone>(802) 847-8174</phone>
    <email>Roz.Bidad@uvmhealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Champlain Valley Physician's Hospital</name>
      <address>
        <city>Plattsburgh</city>
        <state>New York</state>
        <zip>12901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roz Bidad, RN</last_name>
      <phone>802-847-8174</phone>
      <email>Roz.Bidad@uvmhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roz Bidad, RN</last_name>
      <phone>802-847-8174</phone>
      <email>Roz.Bidad@uvmhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Porter Medical Center</name>
      <address>
        <city>Middlebury</city>
        <state>Vermont</state>
        <zip>05753</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roz Bidad, RN</last_name>
      <phone>802-847-8174</phone>
      <email>Roz.Bidad@uvmhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>August 5, 2020</last_update_submitted>
  <last_update_submitted_qc>August 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Scott Mackey</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

